Correlation Between Bristol Myers and Valneva SE
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Valneva SE ADR, you can compare the effects of market volatilities on Bristol Myers and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Valneva SE.
Diversification Opportunities for Bristol Myers and Valneva SE
-0.88 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Bristol and Valneva is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Bristol Myers i.e., Bristol Myers and Valneva SE go up and down completely randomly.
Pair Corralation between Bristol Myers and Valneva SE
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 1.0 times more return on investment than Valneva SE. However, Bristol Myers Squibb is 1.0 times less risky than Valneva SE. It trades about 0.2 of its potential returns per unit of risk. Valneva SE ADR is currently generating about -0.61 per unit of risk. If you would invest 5,250 in Bristol Myers Squibb on August 30, 2024 and sell it today you would earn a total of 677.00 from holding Bristol Myers Squibb or generate 12.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Valneva SE ADR
Performance |
| Timeline |
| Bristol Myers Squibb |
| Valneva SE ADR |
Bristol Myers and Valneva SE Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Valneva SE
The main advantage of trading using opposite Bristol Myers and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.| Bristol Myers vs. Emergent Biosolutions | Bristol Myers vs. Bausch Health Companies | Bristol Myers vs. Neurocrine Biosciences | Bristol Myers vs. Teva Pharma Industries |
| Valneva SE vs. Ikena Oncology | Valneva SE vs. Eliem Therapeutics | Valneva SE vs. HCW Biologics | Valneva SE vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |